Get the Stockscreener App
4.31
6.20%
-0.285
Pre-market:
4.30
-0.010
-0.23%
Portage Biotech Inc Stock (PRTG) Latest News
Portage Biotech granted Nasdaq compliance extension By Investing.com - Investing.com Nigeria
Portage Biotech receives extension from Nasdaq to attain listing compliance - MSN
Portage Biotech granted Nasdaq compliance extension - MSN
Portage Biotech Granted Nasdaq Compliance Extension - TipRanks
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements - The Manila Times
Portage Biotech, Inc. Receives Extension to Regain Nasdaq Compliance Following Acceptance of Compliance Plan - Nasdaq
Nasdaq Grants Portage Biotech Critical 18-Month Lifeline to Secure Exchange Status - StockTitan
What is the investor’s view on Portage Biotech Inc (PRTG)? - US Post News
Pre-Market Surge: Portage Biotech (PRTG) Sees Upward Movement - Stocks Telegraph
Portage Biotech Announces Completion of $2.15 Million Private Financing - The Manila Times
Portage Biotech Secures $2.15 Million in Private Financing - TipRanks
Portage Biotech, Inc. Completes $2.15 Million Private Placement to Support Corporate Growth - Nasdaq
Insider Confidence: Portage Directors Invest $2.15M in Strategic Private Placement - StockTitan
Portage Biotech (NASDAQ:PRTG) Stock Price Down 7.2% – Here’s What Happened - Defense World
Portage Biotech Inc. Appoints Peter Molloy as CEO of Subsidiary, Cyncado Therapeutics, Inc - Marketscreener.com
Portage Biotech Re-Launches Subsidiary as Cyncado Therapeutics with New CEO - TipRanks
Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company - The Manila Times
Portage Biotech Launches Cyncado Therapeutics to Pioneer Advanced Cancer Immunotherapy Development - StockTitan
(PRTG) Trading Signals - Stock Traders Daily
(PRTG) Trading Advice - Stock Traders Daily
Portage Biotech Inc (PRTG) Recovers 276.55% From Low: Are We There Yet? - Stocks Register
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Portage Biotech Stock More Than Doubles On Immunova Deal Potential: Retail Sees Big Opportunity - MSN
Portage Biotech Inc. Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd - Marketscreener.com
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Portage Biotech soars after initiating proceedings for iOx Therapeutics sale - Mugglehead
What's Going On With Portage Biotech Shares Tuesday?Portage Biotech (NASDAQ:PRTG) - Benzinga
Crude Oil Down Over 1%; US Industrial Production Declines In November - Benzinga
Portage Biotech (PRTG) Stock Soars Amid Strategic Transaction - Stocks Telegraph
Strategic moves ignite these stocks 🧨 - RagingBull
Portage Biotech Shares Double on Letter of Intent to Sell Subsidiary - MarketWatch
Dow Dips Over 200 Points; US Retail Sales Top Estimates - Benzinga
Clinical Trials News Live Feed - StockTitan
Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova - Fierce Biotech
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd - The Manila Times
Portage Biotech Enters Negotiations with Immunova for iOx Acquisition - TipRanks
Portage Biotech enters LOI with Immunova for subsidiary sale - Investing.com
Portage Biotech Inc. Appoints New CEO Amid Leadership Change - TipRanks
Westport-based Portage Biotech faces delisting from Nasdaq - Hartford Business Journal
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders - Fierce Biotech
Portage Biotech receives Nasdaq non-compliance notice By Investing.com - Investing.com Canada
Portage Biotech receives noncompliance notification from Nasdaq - TipRanks
Portage Biotech Receives Nasdaq Noncompliance Notice - TipRanks
Portage Biotech receives Nasdaq non-compliance notice - Investing.com
Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter - The Manila Times
Full Stock Market News from 2024-12-06 - StockTitan
Portage Biotech Announces Key Leadership Changes - TipRanks
Portage Biotech (NASDAQ:PRTG) Stock Quotes, Forecast and News Summary - Benzinga
Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024 - The Manila Times
Portage Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Portage Biotech Reports Reduced Losses and Strategic Plans - TipRanks
Portage Biotech Narrows Q3 Loss by 73% to $1.4M, Pauses Clinical Trial Amid Strategic Review - StockTitan
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):